1. Ramsey G. Blood component recalls and market withdrawals: frequency, reasons, and management in the United States. Transfus Med Rev. 2013;27(2):82–90.
2. eCFR, Title 21, Chapter I, Subpart F, Part 610. https://ecfr.federalregister.gov/current/title-21/Chapter-I/subChapter-F/part-610. Accessed 16 Aug 2021.
3. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry. Revised recommendations to reduce the risk of transfusion-transmitted Malaria. 2020. https://www.fda.gov/media/72243/download#:~:text=We%20recommend%20that%20you%20defer,all%20other%20donor%20eligibility%20criteria. Accessed 24 Aug 2021.